| Predicted Trait | |
| Reported Trait | Coronary heart disease | 
| Mapped Trait(s) | coronary artery disease (EFO_0001645) | 
| Score Construction | |
| PGS Name | CHD46 | 
| Development Method | |
| Name | Literature-derived SNP selection | 
| Parameters | NR | 
| Variants | |
| Original Genome Build | NR | 
| Number of Variants | 46 | 
| Effect Weight Type | NR | 
| PGS Source | |
| PGS Catalog Publication (PGP) ID | PGP000044 | 
| Citation (link to publication) | Hajek C et al. Circ Genom Precis Med (2018) | 
| Ancestry Distribution | |
| Source of Variant Associations (GWAS) | |
| PGS Evaluation | European: 100% 2 Sample Sets | 
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) | 
|---|---|---|---|
| Europe PMC: 23202125 | [ 
 | European, South Asian | NR | 
| GWAS Catalog: GCST000030 Europe PMC: 17478679 | 8,335 individuals | European | NR | 
| GWAS Catalog: GCST000057 Europe PMC: 17634449 | 4,864 individuals | European | NR | 
| GWAS Catalog: GCST000875 Europe PMC: 21088011 | 2,905 individuals | European | NR | 
| GWAS Catalog: GCST000946 Europe PMC: 21239051 | 7,311 individuals | European | NR | 
| GWAS Catalog: GCST000945 Europe PMC: 21239051 | 2,723 individuals | European | NR | 
| GWAS Catalog: GCST003116 Europe PMC: 26343387 | 4,095 individuals | Hispanic or Latin American | 41 cohorts 
 | 
| GWAS Catalog: GCST003116 Europe PMC: 26343387 | 25,557 individuals | South Asian | 41 cohorts 
 | 
| GWAS Catalog: GCST003116 Europe PMC: 26343387 | 141,217 individuals | European | 41 cohorts 
 | 
| GWAS Catalog: GCST001000 Europe PMC: 21378986 | 460 individuals | East Asian | NR | 
| Europe PMC: 21673312 | [ 
 | European (European ) | NR | 
| GWAS Catalog: GCST001079 Europe PMC: 21606135 | 5,031 individuals | European | NR | 
| GWAS Catalog: GCST001587 Europe PMC: 22751097 | 6,534 individuals | East Asian | BAS, CAS | 
| GWAS Catalog: GCST000338 Europe PMC: 19198612 | 2,520 individuals | European | NR | 
| GWAS Catalog: GCST000999 Europe PMC: 21378988 | 14,790 individuals | South Asian (India, Pakistan) | NR | 
| GWAS Catalog: GCST000999 Europe PMC: 21378988 | 15,682 individuals | European | NR | 
| GWAS Catalog: GCST003116 Europe PMC: 26343387 | 2,268 individuals | Greater Middle Eastern (Middle Eastern, North African or Persian) | 40 cohorts 
 | 
| GWAS Catalog: GCST003116 Europe PMC: 26343387 | 3,139 individuals | African American or Afro-Caribbean | 41 cohorts 
 | 
| GWAS Catalog: GCST003116 Europe PMC: 26343387 | 11,323 individuals | East Asian | 41 cohorts 
 | 
| PGS Performance Metric ID (PPM) | PGS Sample Set ID (PSS) | Performance Source | Trait | PGS Effect Sizes (per SD change) | Classification Metrics | Other Metrics | Covariates Included in the Model | PGS Performance: Other Relevant Information | 
|---|---|---|---|---|---|---|---|---|
| PPM000150 | PSS000094| European Ancestry| 1,320 individuals | PGP000044 | Hajek C et al. Circ Genom Precis Med (2018) | Reported Trait: Incident coronary heart disease | — | — | HR (top vs. bottom quartiles of GRS): 0.76 [0.41, 1.39] p-value (association between risk and incidence): 0.31 | NR | — | 
| PPM000149 | PSS000095| European Ancestry| 1,206 individuals | PGP000044 | Hajek C et al. Circ Genom Precis Med (2018) | Reported Trait: Incident coronary heart disease | — | — | HR (top vs. bottom quartiles of GRS): 1.92 [1.19, 3.11] p-value (association between risk and incidence): 0.029 | NR | — | 
| PGS Sample Set ID (PSS) | Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information | 
|---|---|---|---|---|---|---|---|---|
| PSS000094 | Incident CHD was defined as myocardial infarction (MI), resuscitated cardiac arrest, definite or probable angina if followed by a revascularization and CHD death | — | [ 
 | Mean = 62.6 years | European | Analysis restricted to "White participants" | MESA | — | 
| PSS000095 | Incident CHD was defined as myocardial infarction (MI), resuscitated cardiac arrest, definite or probable angina if followed by a revascularization and CHD death | — | [ 
 | Mean = 62.7 years | European | Analysis restricted to "White participants" | MESA | — |